Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in: | Journal of Virology Vol. 76; no. 2; pp. 484 - 491 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Society for Microbiology
01-01-2002
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a recombinant vaccinia virus vaccine (v2RVFH) that expresses both the fusion (F) and hemagglutinin (H) genes of rinderpest virus (RPV) under strong synthetic vaccinia virus promoters. v2RVFH-infected cells express high levels of the F and H glycoproteins and show extensive syncytium formation. Cattle vaccinated intramuscularly with as little as 10
3
PFU of v2RVFH and challenged 1 month later with a lethal dose of RPV were completely protected from clinical disease; the 50% protective dose was determined to be 10
2
PFU. Animals vaccinated with v2RVFH did not develop pock lesions and did not transmit the recombinant vaccinia virus to contact animals. Intramuscular vaccination of cattle with 10
8
PFU of v2RVFH provided long-term sterilizing immunity against rinderpest. In addition to being highly safe and efficacious, v2RVFH is a heat-stable, inexpensive, and easily administered vaccine that allows the serological differentiation between vaccinated and naturally infected animals. Consequently, mass vaccination of cattle with v2RVFH could eradicate rinderpest. ABSTRACT Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a recombinant vaccinia virus vaccine (v2RVFH) that expresses both the fusion (F) and hemagglutinin (H) genes of rinderpest virus (RPV) under strong synthetic vaccinia virus promoters. v2RVFH-infected cells express high levels of the F and H glycoproteins and show extensive syncytium formation. Cattle vaccinated intramuscularly with as little as 10 3 PFU of v2RVFH and challenged 1 month later with a lethal dose of RPV were completely protected from clinical disease; the 50% protective dose was determined to be 10 2 PFU. Animals vaccinated with v2RVFH did not develop pock lesions and did not transmit the recombinant vaccinia virus to contact animals. Intramuscular vaccination of cattle with 10 8 PFU of v2RVFH provided long-term sterilizing immunity against rinderpest. In addition to being highly safe and efficacious, v2RVFH is a heat-stable, inexpensive, and easily administered vaccine that allows the serological differentiation between vaccinated and naturally infected animals. Consequently, mass vaccination of cattle with v2RVFH could eradicate rinderpest. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a recombinant vaccinia virus vaccine (v2RVFH) that expresses both the fusion (F) and hemagglutinin (H) genes of rinderpest virus (RPV) under strong synthetic vaccinia virus promoters. v2RVFH-infected cells express high levels of the F and H glycoproteins and show extensive syncytium formation. Cattle vaccinated intramuscularly with as little as 10(3) PFU of v2RVFH and challenged 1 month later with a lethal dose of RPV were completely protected from clinical disease; the 50% protective dose was determined to be 10(2) PFU. Animals vaccinated with v2RVFH did not develop pock lesions and did not transmit the recombinant vaccinia virus to contact animals. Intramuscular vaccination of cattle with 10(8) PFU of v2RVFH provided long-term sterilizing immunity against rinderpest. In addition to being highly safe and efficacious, v2RVFH is a heat-stable, inexpensive, and easily administered vaccine that allows the serological differentiation between vaccinated and naturally infected animals. Consequently, mass vaccination of cattle with v2RVFH could eradicate rinderpest. Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a recombinant vaccinia virus vaccine (v2RVFH) that expresses both the fusion (F) and hemagglutinin (H) genes of rinderpest virus (RPV) under strong synthetic vaccinia virus promoters. v2RVFH-infected cells express high levels of the F and H glycoproteins and show extensive syncytium formation. Cattle vaccinated intramuscularly with as little as 10 PFU of v2RVFH and challenged 1 month later with a lethal dose of RPV were completely protected from clinical disease; the 50% protective dose was determined to be 10 PFU. Animals vaccinated with v2RVFH did not develop pock lesions and did not transmit the recombinant vaccinia virus to contact animals. Intramuscular vaccination of cattle with 10 PFU of v2RVFH provided long-term sterilizing immunity against rinderpest. In addition to being highly safe and efficacious, v2RVFH is a heat-stable, inexpensive, and easily administered vaccine that allows the serological differentiation between vaccinated and naturally infected animals. Consequently, mass vaccination of cattle with v2RVFH could eradicate rinderpest. |
Author | Mebratu G. Yesus Berhanu Beyene Paulo H. Verardi Shabbir Ahmad Tilahun D. Yilma Berhe G. Egziabher Leslie A. Jones Henry M. Wamwayi Fatema H. Aziz Rosemary N. Ngotho |
AuthorAffiliation | International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California 95616, 1 National Veterinary Institute, Debre-Zeit, Ethiopia, 2 Kenya Agricultural Research Institute, Kikuyu, Kenya 3 |
AuthorAffiliation_xml | – name: International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California 95616, 1 National Veterinary Institute, Debre-Zeit, Ethiopia, 2 Kenya Agricultural Research Institute, Kikuyu, Kenya 3 |
Author_xml | – sequence: 1 givenname: Paulo H surname: Verardi fullname: Verardi, Paulo H organization: International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California 95616, USA – sequence: 2 givenname: Fatema H surname: Aziz fullname: Aziz, Fatema H – sequence: 3 givenname: Shabbir surname: Ahmad fullname: Ahmad, Shabbir – sequence: 4 givenname: Leslie A surname: Jones fullname: Jones, Leslie A – sequence: 5 givenname: Berhanu surname: Beyene fullname: Beyene, Berhanu – sequence: 6 givenname: Rosemary N surname: Ngotho fullname: Ngotho, Rosemary N – sequence: 7 givenname: Henry M surname: Wamwayi fullname: Wamwayi, Henry M – sequence: 8 givenname: Mebratu G surname: Yesus fullname: Yesus, Mebratu G – sequence: 9 givenname: Berhe G surname: Egziabher fullname: Egziabher, Berhe G – sequence: 10 givenname: Tilahun D surname: Yilma fullname: Yilma, Tilahun D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11752138$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks9uEzEQxleoFU0LjwDyidsGj9f778ABRW0TFKlSKRE3y-udbFzt2sH2pg1PxGPiKFGBE6eRZn7fp7Hnu0zOjDWYJO-ATgFY9fHLajEtiymb8oqnvIYpo5S9SiZA6yrNc-BnySR2WJpn1feL5NL7R0qB84K_Ti4AypxBVk2SX0truvQB3UC-BnS61z-16chiGEajw54ES-61adFt0QeiDZnJEHokK6mUNjJgS5502BBJ7lHZoYk9E05TLclKu9GT6-etQ-8PxnPdbcgSd9h7YtckbJDcjF5bQ6RpyRwH2XX9GKLYkNt-r-zW2YDa-DfJ-Vr2Ht-e6lXy7eb6YTZPl3e3i9nnZap4wUJaQSFL1SqaZ-uG5k2Zt5RzVfEMqMSSrVvGWVFlTEEmZV0rxII1ZVOrpgWoMbtKPh19t2MzYKvQBCd7sXV6kG4vrNTi34nRG9HZnYCsqKCM-g8nvbM_xvhpYtBeYd9Lg3b0ooSMlyXAf0GoGNS0ohHMj6By1nuH65dlgIpDFkTMgigLwUTMgohZEIcsRN37v1_yR3U6fgTIEdjEozxph0L6QTzu9ItZ9hvEk8Ht |
CitedBy_id | crossref_primary_10_3390_vaccines10020245 crossref_primary_10_1016_S0264_410X_03_00192_0 crossref_primary_10_1073_pnas_0409846102 crossref_primary_10_4161_hv_21080 crossref_primary_10_1016_j_vaccine_2008_09_044 crossref_primary_10_1016_S0749_0720_02_00035_X crossref_primary_10_1007_s12088_010_0026_9 crossref_primary_10_1007_s00705_010_0705_1 crossref_primary_10_1016_j_virusres_2011_09_038 crossref_primary_10_1073_pnas_1112149108 crossref_primary_10_1089_vim_2004_17_401 crossref_primary_10_1371_journal_pone_0230711 crossref_primary_10_1016_j_vaccine_2014_05_025 crossref_primary_10_1016_j_virol_2004_02_030 crossref_primary_10_1586_14760584_4_1_113 crossref_primary_10_1016_j_vetmic_2017_01_010 crossref_primary_10_1128_JVI_01446_08 crossref_primary_10_1186_1297_9716_45_24 crossref_primary_10_2903_j_efsa_2022_7071 crossref_primary_10_1016_S0378_1135_03_00201_3 crossref_primary_10_1089_jir_2013_0052 crossref_primary_10_1016_j_vaccine_2010_04_102 |
Cites_doi | 10.1017/S0950268800052535 10.1016/S0034-5288(18)34916-6 10.1073/pnas.88.18.8011 10.1542/peds.18.1.109 10.1038/317813a0 10.1016/S0264-410X(98)00446-0 10.1017/S0022172400064524 10.1006/viro.2000.0564 10.1006/viro.1994.1016 10.1017/S0950268896007200 10.1128/jvi.69.6.3341-3349.1995 10.1073/pnas.89.8.3409 10.1099/0022-1317-81-6-1439 10.1128/jvi.65.8.4263-4274.1991 10.1016/0042-6822(88)90156-0 10.1073/pnas.81.22.7194 10.1016/S0065-3519(99)80043-3 10.1128/jvi.61.12.3896-3901.1987 10.1016/0042-6822(88)90265-6 10.1016/S0034-5288(18)32424-X 10.1136/vr.145.10.275 10.2144/97236st07 10.1016/S0065-3527(08)60344-9 10.1126/science.3194758 10.1007/BF02388257 10.1016/0042-6822(92)90552-Z 10.1016/0264-410X(94)90341-7 10.1128/JVI.75.1.11-18.2001 10.1099/0022-1317-72-2-439 10.1073/pnas.93.21.11341 10.1136/vr.142.24.669 10.1016/0378-1135(90)90032-Q 10.1128/mcb.5.12.3403-3409.1985 10.1128/jvi.67.3.1255-1261.1993 10.1038/312163a0 |
ContentType | Journal Article |
Copyright | Copyright © 2002, American Society for Microbiology 2002 |
Copyright_xml | – notice: Copyright © 2002, American Society for Microbiology 2002 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7T5 7U9 8FD FR3 H94 P64 7X8 5PM |
DOI | 10.1128/JVI.76.2.484-491.2002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 491 |
ExternalDocumentID | 10_1128_JVI_76_2_484_491_2002 11752138 jvi_76_2_484 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: AI47025 – fundername: NIAID NIH HHS grantid: AI36197 – fundername: NIAID NIH HHS grantid: AI37182 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAYJJ ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F20 F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM AAYXX CITATION 7QO 7T5 7U9 8FD FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c462t-816a7cdc053fb05b75d044c84310ae72fd2426832c13aa99cee62b7b9cbd119e3 |
IEDL.DBID | RPM |
ISSN | 0022-538X |
IngestDate | Tue Sep 17 20:31:41 EDT 2024 Fri Oct 25 21:56:46 EDT 2024 Fri Oct 25 11:49:44 EDT 2024 Thu Sep 12 19:50:43 EDT 2024 Sat Sep 28 08:34:10 EDT 2024 Wed May 18 15:30:41 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-816a7cdc053fb05b75d044c84310ae72fd2426832c13aa99cee62b7b9cbd119e3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Corresponding author. Mailing address: International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616. Phone: (530) 752-8306. Fax: (530) 752-1354. E-mail: tdyilma@ucdavis.edu. |
OpenAccessLink | https://doi.org/10.1128/jvi.76.2.484-491.2002 |
PMID | 11752138 |
PQID | 18219080 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_71347711 pubmedcentral_primary_oai_pubmedcentral_nih_gov_136817 crossref_primary_10_1128_JVI_76_2_484_491_2002 pubmed_primary_11752138 highwire_asm_jvi_76_2_484 proquest_miscellaneous_18219080 |
PublicationCentury | 2000 |
PublicationDate | 2002-01-01 |
PublicationDateYYYYMMDD | 2002-01-01 |
PublicationDate_xml | – month: 01 year: 2002 text: 2002-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2002 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 (e_1_3_2_29_2) 1968; 3 (e_1_3_2_39_2) 1987; 35 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_8_2) 1994 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 (e_1_3_2_14_2) 1995; 137 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 (e_1_3_2_18_2) 1991; 10 e_1_3_2_35_2 (e_1_3_2_42_2) 1987 |
References_xml | – ident: e_1_3_2_26_2 doi: 10.1017/S0950268800052535 – ident: e_1_3_2_30_2 doi: 10.1016/S0034-5288(18)34916-6 – ident: e_1_3_2_9_2 doi: 10.1073/pnas.88.18.8011 – ident: e_1_3_2_11_2 doi: 10.1542/peds.18.1.109 – ident: e_1_3_2_5_2 doi: 10.1038/317813a0 – ident: e_1_3_2_27_2 doi: 10.1016/S0264-410X(98)00446-0 – ident: e_1_3_2_28_2 doi: 10.1017/S0022172400064524 – ident: e_1_3_2_44_2 doi: 10.1006/viro.2000.0564 – ident: e_1_3_2_15_2 doi: 10.1006/viro.1994.1016 – volume: 10 start-page: 564 year: 1991 ident: e_1_3_2_18_2 publication-title: BioTechniques – ident: e_1_3_2_23_2 doi: 10.1017/S0950268896007200 – ident: e_1_3_2_24_2 doi: 10.1128/jvi.69.6.3341-3349.1995 – ident: e_1_3_2_10_2 doi: 10.1073/pnas.89.8.3409 – volume: 137 start-page: 669 year: 1995 ident: e_1_3_2_14_2 publication-title: Vet. Rec. – ident: e_1_3_2_25_2 doi: 10.1099/0022-1317-81-6-1439 – ident: e_1_3_2_34_2 doi: 10.1128/jvi.65.8.4263-4274.1991 – ident: e_1_3_2_13_2 doi: 10.1016/0042-6822(88)90156-0 – ident: e_1_3_2_40_2 doi: 10.1073/pnas.81.22.7194 – ident: e_1_3_2_19_2 doi: 10.1016/S0065-3519(99)80043-3 – volume: 3 start-page: 25 year: 1968 ident: e_1_3_2_29_2 publication-title: Virol. Monogr. – ident: e_1_3_2_37_2 doi: 10.1128/jvi.61.12.3896-3901.1987 – ident: e_1_3_2_12_2 doi: 10.1016/0042-6822(88)90265-6 – ident: e_1_3_2_31_2 doi: 10.1016/S0034-5288(18)32424-X – ident: e_1_3_2_36_2 – start-page: 16.17.1 year: 1994 ident: e_1_3_2_8_2 publication-title: Current protocols in molecular biology, vol. 2 – ident: e_1_3_2_17_2 doi: 10.1136/vr.145.10.275 – start-page: 393 year: 1987 ident: e_1_3_2_42_2 publication-title: Vaccine 87: modern approaches to new vaccines: prevention of AIDS and other viral, bacterial, and parasitic diseases – ident: e_1_3_2_7_2 doi: 10.2144/97236st07 – ident: e_1_3_2_3_2 doi: 10.1016/S0065-3527(08)60344-9 – ident: e_1_3_2_43_2 doi: 10.1126/science.3194758 – ident: e_1_3_2_20_2 doi: 10.1007/BF02388257 – ident: e_1_3_2_32_2 doi: 10.1016/0042-6822(92)90552-Z – ident: e_1_3_2_33_2 doi: 10.1016/0264-410X(94)90341-7 – ident: e_1_3_2_35_2 – ident: e_1_3_2_38_2 doi: 10.1128/JVI.75.1.11-18.2001 – ident: e_1_3_2_41_2 doi: 10.1099/0022-1317-72-2-439 – ident: e_1_3_2_22_2 doi: 10.1073/pnas.93.21.11341 – ident: e_1_3_2_2_2 doi: 10.1136/vr.142.24.669 – ident: e_1_3_2_21_2 doi: 10.1016/0378-1135(90)90032-Q – volume: 35 start-page: 318 year: 1987 ident: e_1_3_2_39_2 publication-title: Bull. Anim. Health Prod. Afr. – ident: e_1_3_2_6_2 doi: 10.1128/mcb.5.12.3403-3409.1985 – ident: e_1_3_2_4_2 doi: 10.1128/jvi.67.3.1255-1261.1993 – ident: e_1_3_2_16_2 doi: 10.1038/312163a0 |
SSID | ssj0014464 |
Score | 1.8583477 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a recombinant... ABSTRACT Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater than 90% mortality. We have constructed a... |
SourceID | pubmedcentral proquest crossref pubmed highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 484 |
SubjectTerms | AF gene AH gene Animals Cattle Cattle Diseases - immunology Cattle Diseases - prevention & control Cattle Diseases - virology Cells, Cultured Cercopithecus aethiops F gene Giant Cells - pathology Giant Cells - virology H gene Hemagglutinins, Viral - biosynthesis Hemagglutinins, Viral - genetics Hemagglutinins, Viral - immunology Injections, Intramuscular Morbillivirus - genetics Morbillivirus - immunology Neutralization Tests Precipitin Tests Recombinant Fusion Proteins - biosynthesis Recombinant Fusion Proteins - immunology Recombinant Fusion Proteins - metabolism Rinderpest - immunology Rinderpest - prevention & control Rinderpest - virology Rinderpest virus Survival Rate Time Factors Vaccination Vaccines and Antiviral Agents Vaccines, Synthetic - adverse effects Vaccines, Synthetic - genetics Vaccines, Synthetic - immunology Vaccinia virus Vaccinia virus - genetics Vero Cells Viral Proteins - biosynthesis Viral Proteins - genetics Viral Proteins - immunology Viral Vaccines - adverse effects Viral Vaccines - genetics Viral Vaccines - immunology |
Title | Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins |
URI | http://jvi.asm.org/content/76/2/484.abstract https://www.ncbi.nlm.nih.gov/pubmed/11752138 https://search.proquest.com/docview/18219080 https://search.proquest.com/docview/71347711 https://pubmed.ncbi.nlm.nih.gov/PMC136817 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboSkhcEG_C8vCBa9I4cV5HVFq6aEGIXaq9WX6lBDVO1TQryi_iZzJ2kmUXwYWzndjSvMcz3yD0mqoUVC_RvpSF8qlMSj8XSvs0LgnNolAKaVMDy7Ps40X-dm5hcujYC-OK9qWoArOpA1N9dbWV21pOxzqx6acPMxKnOcmmEzQB13CM0IeXAwhv6IgQDsJ8MXTtgBqevl-dBFkaRAHNqU8LFx26aTZgQiNiO1Sum6YRLvhvruefFZTXTNLiHro7-JL4TX_n--iWNg_Q7X665OEh-nnamLV_DqoXn1lE5k31A-wUPnEdIfsD3jf4swVL3G3hUFwZPHOAxnjFpawM-KAK2ywt5tjGqLVwNTPDasXxqtp1LZ5_7ytp4ce2ZASf2iKkFjclBs8SLzqbjMPcKLzUNV-vLZ8bOOrd5iAbhxFRmfYR-rKYn8-W_jCYwZc0jfZ-TlKeSSVBgEsRJiJLVEipzMEZCbnOolJZww-6QpKY86IAbkgjkYlCCkVIoePH6Mg0Rj9FGPytVCZCE5kmVNBIqFDnoIZEQkQstfJQMNKEbXv8DebilihnQE-WpSxiQE8G9LQjNSMPeSPlGG9r9u2yutrkoVcjKRlIkX0a4UY3XcsgygLPKA__vcP13GaEeOhJT_rf1xnYx0PpDaa42mARvG-uAGM7JO-ekZ_974fH6I4bTuMyQs_R0X7X6Rdo0qrupROKX_mzFDY |
link.rule.ids | 230,315,729,782,786,887,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbYEGIv3GHhNj_wmjROnNsjKi0tdBNipdqb5VtLUOtUTYsov4ifybGTjA3By57tJI78nZt9zncQekNVCqqXaF_KQvlUJnM_F0r7NJ4TmkWhFNIeDYzOs7OL_N3A0uTQrhbGJe1LUQZmuQpM-dXlVq5XstflifU-nfZJnOYk6x2g2yCuYdzF6O3dAQQ4tOMIh_GLtm4HFHHvw2wcZGkQBTSnPi1cfOj62YARjYitUblqnDrC4H85n3_nUF4xSsP7N_udB-he64Tit83oQ3RLm0foTtOWcv8Y_ZpUZuFPQWfjc0vlvCx_goHDY1dKst3jbYU_W5bFzRrWikuD-44JGc-4lKUB51Vhe7yLObbB7Uq4ZJt2tOR4Vm52NR78aFJw4cU21wRPbPZSjas5BpcUD3f2FA9zo_BIr_hiYQXEwKfeL_eycuQSpamfoC_DwbQ_8tuODr6kabT1c5LyTCoJkj8XYSKyRIWUyhy8mJDrLJor6zGAkpEk5rwoAEZpJDJRSKEIKXT8FB2ayuhjhMFRS2UiNJFpQgWNhAp1DvpLJETEUisPBd1WsnVD3MFcwBPlDGDAspRFDGDAAAa2F2fkIa_bcMbrFfv2vbyc5KGTDgEMxM_eqXCjq13NIDwDlyoP_z_DFetmhHjoWYOYP8tpUeeh9BqWLidY6u_rIwAhRwHeQOb5TR88QXdH09MJm4zPPr5AR67DjTtWeokOt5udfoUOarV77eTqNznyKYo |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbYEIgX7oNwmx94TRqnzu0RdS0tlGlio9qb5VtKUOtUTTut_CJ-JsdOMjYEL3u2kzjy53PzOd9B6D1VCYheon0pc-VTGRd-JpT2ab8gNI1CKaQNDYxP0-Pz7GhoaXKyrhbGJe1LUQZmsQxM-d3lVq6WstflifVOvgxIP8lI2luporeH7sKRDePOT2_vD8DJoR1POIyft7U7IIx7n2aTIE2CKKAZ9WnufETX0wYUaURsncp1BdWRBv_LAP07j_KaYho9uv0vPUYPW2MUf2hmPEF3tHmK7jXtKXfP0K9pZeb-GchufGopnRflT1B0eOJKSjY7vKnwV8u2uF7BenFp8MAxIuMZl7I0YMQqbMO8mGPr5C6FS7ppR0uOZ-V6W-PhZZOKCy-2OSd4arOYalwVGExTPNraaB7mRuGxXvL53B4UA5_6uNjJypFMlKZ-jr6NhmeDsd92dvAlTaKNn5GEp1JJkACFCGORxiqkVGZgzYRcp1GhrOUAwkaSPud5DnBKIpGKXApFSK77B2jfVEa_RBgMtkTGQhOZxFTQSKhQZyDHRExEX2rloaDbTrZqCDyYc3yijAEUWJqwiAEUGEDB9uSMPOR1m854vWQ_LsqrSR467FDA4BjauxVudLWtGbhpYFpl4f9nuKLdlBAPvWhQ82c5LfI8lNzA09UESwF-cwRg5KjAG9i8uu2Dh-j-ydGITSfHn1-jB67RjYsuvUH7m_VWv0V7tdq-c0frN3IGLAo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Sterilizing+Immunity+to+Rinderpest+in+Cattle+Vaccinated+with+a+Recombinant+Vaccinia+Virus+Expressing+High+Levels+of+the+Fusion+and+Hemagglutinin+Glycoproteins&rft.jtitle=Journal+of+virology&rft.au=Verardi%2C+PH&rft.au=Aziz%2C+F+H&rft.au=Ahmad%2C+S&rft.au=Jones%2C+LA&rft.date=2002-01-01&rft.issn=0022-538X&rft.volume=76&rft.issue=2&rft.spage=484&rft.epage=491&rft_id=info:doi/10.1128%2FJVI.76.2.484-491.2002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |